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ABSTRACT
Chikungunya Virus Is A Mosquito-borne Alpha Virus Which Occasionally Causes Neurologic Complications Including 
Guillain-barre Syndrome, Myelitis, Myopathies And Encephalitis. Pakistan Experienced Its First Chikungunya Outbreak 
In The Metropolis Of Karachi Officially Confirmed By World Health Organization In December 2016. During This 
Outbreak, Over 30,000 People Have Been Reported To Be Infected In Different Parts Of Karachi. We Report Four Cases 
Of Chikungunya Virus Infection Associated Guillain-barre Syndrome Having An Atypical Clinical Presentation And 
Variable Outcome. Each Case Presented As A Different Variant Of Gbs Including Acute Inflammatory Demyelinating 
Polyneuropathy, Acute Motor And Sensory Axonal Neuropathy And Pharyngeal-cervical-brachial.
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O R I G I N A L  A R T I C L E
INTRODUCTION: Chikungunya Is A Mosquito-borne 
Arbovirus Which Presents With Rapid Onset Of Fever, 
Fatigue, Myalgia, Arthralgias And Rash(1). Neurological 
Manifestations Are Less Commonly Reported And 
Include Meningoencephalitis, Acute Flaccid Paralysis, 
Guillain-barré Syndrome, Myelitis, Seizures And Cranial 
Nerve Palsies(2, 3). 
Guillain-barré Syndrome (Gbs) Is The Most Common 
Acute Immune-mediated Polyradiculoneuropathy 
Typically Presenting With Sensory Symptoms And 
Weakness Over Several Days, Often Leading To 
Quadriparesis. In Two-thirds Of Patients, Gbs Occurs 
After An Infection And Is Generally Considered 
Secondary To Immune-mediated Response. The Most 
Commonly Associated Infection Is C. Jejuni, While 
Other Common Infections Include Cytomegalovirus, 
Epstein-barr Virus, Mycoplasma Pneumoniae, And 
Haemophilus Influenza(4). However, Only A Few Cases 
Of Gbs Have Been Reported After Infection With 
Chikungunya Virus.
Pakistan Recently Experienced Its First Outbreak Of 
Chikungunya Virus In The Metropolis Of Karachi(5). 
Here We Report Our Experience With Four Cases Of 
Acute And Severe Gbs Associated With Chikungunya 
Virus Infection From Pakistan. Each Case Presented As 
A Different Variant Of Gbs Including Acute Inflammatory 
Demyelinating Polyneuropathy (Aidp), Acute Motor And 
Sensory Axonal Neuropathy (Amsan) And 
Pharyngeal-cervical-brachial (Pcb). Although Gbs Has 
Been Reported With Chikungunya Virus Infection, To 
The Best Of Our Knowledge There Has Been No Report 
On Variants Of Gbs Such As Amsan And Pcb After 
Chikungunya Virus Infection. The Atypical Neurological 
Presentation Has Been A Challenge For Early Diagnosis 
And Timely Management, Therefore We Discuss The 
Clinical Course And The Subsequent Variable Outcomes 
Observed In These Cases.
PATIENT 1:
A 42-year-old woman with no prior co-morbid was 
admitted with a ten-day history of intermittent 
high-grade fever, myalgia, and severe generalized joint 
pain. The patient was conservatively managed as viral 
fever with symptomatic medications. Patient’s fever 
gradually resolved by the sixth day of symptoms but her 
joint pain continued to restrict her mobility. On day 
seven, she experienced numbness on the left lower 
extremity followed by right lower extremity in the later 
course of the day. Next day the patient developed 
bilateral lower limb weakness without any bowel or 
bladder symptoms. The patient’s weakness was 
progressive involving upper limbs and also the face 
bilaterally with lower motor neuron type weakness. 
During the hospital course, the patient developed 
respiratory distress and was put on non-invasive BIPAP 
(Bilevel Positive Airway Pressure) support. The initial 
neurological exam revealed a power of 2/5 in bilateral 
upper limbs proximally and distally and 1/5 in the lower 
limbs along with weak flexors of the neck. Reflexes 
were absent in bilateral knee and ankle and +1 in the 
bicep and triceps bilaterally with a patchy sensory loss. 
Electrophysiological studies were done which showed 
acute motor sensory axonal neuropathy (AMSAN) 
shown in table 1. She underwent five sessions of 
plasma exchange, with a volume of two liters in each 
session. Weakness improved to a power of 4/5 in upper 
limbs and 3/5 in lower limbs with improved breathing 
after completion of five sessions. The IgM chikungunya 
antibody was detected in serum while CSF PCR was 
negative. The CSF DR showed albuminocytological 
dissociation (table 2). She was discharged and had 
complete recovery of power at one month seen in clinic 
follow-up.
PATIENT 2:
A 61-year-old gentleman who was a known case of 
diabetes, hypertension and dyslipidemia. The patient 
presented with numbness of bilateral feet and gait 
difficulties. He had a recent febrile illness 4-5 day prior 
to admission. He presented to neurology with unsteady 
gait with a normal neurological exam except for 
bilaterally absent ankle reflexes. He underwent an 
electrophysiological study that was suggestive of acute 
inflammatory demyelinating polyneuropathy (AIDP) 
(table1).  CSF analysis showed Protein 60 mg/dl, CSF 
TLC 14 (Poly 60%), CSF GLUCOSE 77 mg/dl with serum 
glucose 118 mg/dl. The blood workup for fever 
including dengue and chikungunya serology, malarial 
parasite and blood culture were sent and chikungunya 
IgM was detected.
The patient had progressive weakness involving all four 
limbs followed by severe respiratory distress and had to 
be intubated. There was no meaningful recovery 
requiring continuous respiratory support after five 
cycles of plasma exchange. He was later given 5 doses 
of IVIG which did not improve his condition. He had to 
undergo tracheostomy due to the prolonged ventilator 
support and after a month-long complicated hospital 
course, he eventually died. 
PATIENT 3:
A 43-year gentleman presented with progressive limb 
numbness and weakness with gait difficulty for 20 
days. The limb numbness initially began in bilateral 
lower limbs slowly involving the upper limbs in a glove 
and stocking pattern. He had a history of viral fever two 
weeks prior to the current symptoms. The fever was 
high grade, continuous and associated with arthralgia 
and myalgia. 
The initial neurological exam revealed a muscle 
strength of bilateral upper limb proximally 5/5 and 
distally 4/5 and in bilateral lower limb proximally and 
distally 4/5. Reflexes were absent at bilateral knee and 
ankle joints and were +1 in the bicep and triceps 
bilaterally. Sensory examination revealed decreased 
sensation in bilateral lower limbs up to the mid-thigh 
and upper limbs up to mid forearm. The nerve 
conduction study with needle electromyography was 
suggestive of acute inflammatory demyelinating 
polyneuropathy (AIDP).  CSF analysis showed 
albuminocytological dissociation as described in table 
2. The chikungunya IgM came out to be positive. He 
had five sessions of plasma exchange and significant 
clinical improvement. 
PATIENT 4:
A 36-year old right-handed lady with no prior co-morbid 
presented with sudden onset of difficulty in swallowing 
for three days followed by left arm weakness for a day. 
She had a high-grade fever associated with arthralgia 
and myalgia, severe in intensity, 3 months prior to this 
weakness. The initial neurological examination revealed 
a hypernasal speech, Right facial weakness of lower 
motor neuron type with symmetrical bulbar weakness. 
Her motor exam revealed a muscle power of -4/5 
proximally and +4/5 distally in the left upper extremity. 
The rest of the muscle groups in all other extremities 
were within normal limits. The left biceps and triceps 
reflexes were diminished (+1) with the rest of the 
reflexes being normal (+2).
She was initially suspected as a case of brainstem 
stroke and underwent MRI brain which turned out 
normal. Meanwhile, the weakness progressed involving 
the neck muscles with a power of 2/5 in the neck 
flexors and extensors. The left upper limb proximally 
was 2/5 and distally 3/5 with absent biceps and triceps 
reflexes and there was involvement of the right upper 
limb proximally the muscle strength was -4/5 and 
distally 3/5 with diminished biceps and triceps reflexes. 
The progressive bulbar, neck and asymmetric upper 
limb weakness with areflexia strongly suggested the 
diagnosis of pharyngeal-cervical-brachial (PCB) variant 
of Guillain–Barré syndrome. Myasthenia Gravis was 
ruled out by performing repeated nerve stimulation. A 
test for botulinum toxin in stool or serum was not 
performed. 
Electrophysiological showed a delayed blink reflex 
bilaterally with rapid firing units on needle electrode 
examination (table 1). CSF analysis was within normal 
limits (table 2).  Considering the prior history of fever 
associated with generalized body ache prior to this 
weakness, Chikungunya IgM serology was sent which 
came out to be positive. She was started on IVIG 
(0.4g/kg/day) but during the first day of treatment she 
progressively developed respiratory distress with type 2 
respiratory failures and had to be intubated. By day 4 of 
IVIG, she had regained some neck muscle strength and 
was extubated. She was later discharged with residual 
bulbar and facial weakness, which had completely 
resolved at one month of follow up.
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DISCUSSION:
We report the first four cases of patients developing 
GBS after infection with the chikungunya virus from 
Pakistan. While cases of GBS after infection with 
chikungunya virus have been reported before, they 
remain rare. To the best of our knowledge 17 cases of 
GBS after infection with chikungunya virus have been 
reported (1, 6-9). There is no report of this feature from 
Pakistan in any of the recent or previous outbreaks. 
Additionally, while there are case reports on AMAN 
(acute motor axonal neuropathy) and AIDP (Acute 
inflammatory demyelinating polyneuropathy) variant of 
GBS associated with chikungunya virus, we report the 
first associated case of PCB 
(Pharyngeal-cervical-brachial) and AMSAN (acute 
motor and sensory axonal neuropathy) variants of GBS. 
The diagnosis of chikungunya virus infection was based 
on Anti- chikungunya virus immunoglobulin M (IgM). 
This is detected after 3-5 days of infections and 
remains elevated for 3-6 months(10). GBS was 
diagnosed on the clinical presentation along with 
findings on electrodiagnostic studies. The presence of 
Anti- chikungunya virus IgM and the absence of signs of 
other commonly associated infections and the outbreak 
of chikungunya virus was taken to mean that GBS was 
related to the chikungunya virus infection. Similar to 
our case the other reported cases happened during 
outbreaks of chikungunya virus and an increase in the 
incidence of GBS has been reported during these 
outbreaks(6). Hence index of suspicion for GBS should 
be kept high in places with chikungunya outbreak. 
Three of our four patients had mildly elevated 
leukocytes in the CSF. This finding was not present in 
any of the other cases reported in literature.
All four patients in our series had a prior history of fever 
associated with either arthralgia or myalgia lasting for 
2-12 days. There was a symptom-free interval between 
the chikungunya virus infection and the onset of 
weakness, the duration of which varied from 5 days to 
3 months. This variation is comparable to the reported 
cases which show an onset of symptoms 3 days to 40 
days after initially experiencing fever, myalgias and 
arthralgias(1, 6-9). The course was typically 
aggressive, with 3 of our 4 patients (75%) requiring 
ventilatory support with there being one mortality. In 
the previous 17 cases reported, 6 patients (35%) 
required ventilatory support. This figure is comparable 
to the rate of respiratory failure in GBS of one patient in 
three reported in the literature(11). There were no 
deaths reported in GBS associated with chikungunya in 
the previous reports.
Of note, was the diagnostic challenge encountered in 
the fourth case with pharyngeal-cervical-brachial (PCB) 
variant of Guillain–Barré syndrome. The predominant 
signs of brainstem weakness in our case suggested a 
stroke. This, along with unfamiliarity with PCB variant of 
GBS meant early diagnosis was focused on ruling out a 
stroke. In patients with a history suggestive of features 
not consistent with a stroke, PCB should be 
considered, as early diagnosis and treatment can 
improve outcome.
CONCLUSION:
Patients may present with GBS after infection with 
chikungunya virus. This includes multiple variants of 
GBS including AIDP, AMAN, AMSAN and PCB. In places, 
with a chikungunya virus outbreak, there should be a 
high index of suspicion for GBS since this can lead to a 
timely diagnosis and treatment as the cases had a 
rapidly progressive disease course, especially 
progressing quickly to respiratory and bulbar symptoms.
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joint pain continued to restrict her mobility. On day 
seven, she experienced numbness on the left lower 
extremity followed by right lower extremity in the later 
course of the day. Next day the patient developed 
bilateral lower limb weakness without any bowel or 
bladder symptoms. The patient’s weakness was 
progressive involving upper limbs and also the face 
bilaterally with lower motor neuron type weakness. 
During the hospital course, the patient developed 
respiratory distress and was put on non-invasive BIPAP 
(Bilevel Positive Airway Pressure) support. The initial 
neurological exam revealed a power of 2/5 in bilateral 
upper limbs proximally and distally and 1/5 in the lower 
limbs along with weak flexors of the neck. Reflexes 
were absent in bilateral knee and ankle and +1 in the 
bicep and triceps bilaterally with a patchy sensory loss. 
Electrophysiological studies were done which showed 
acute motor sensory axonal neuropathy (AMSAN) 
shown in table 1. She underwent five sessions of 
plasma exchange, with a volume of two liters in each 
session. Weakness improved to a power of 4/5 in upper 
limbs and 3/5 in lower limbs with improved breathing 
after completion of five sessions. The IgM chikungunya 
antibody was detected in serum while CSF PCR was 
negative. The CSF DR showed albuminocytological 
dissociation (table 2). She was discharged and had 
complete recovery of power at one month seen in clinic 
follow-up.
PATIENT 2:
A 61-year-old gentleman who was a known case of 
diabetes, hypertension and dyslipidemia. The patient 
presented with numbness of bilateral feet and gait 
difficulties. He had a recent febrile illness 4-5 day prior 
to admission. He presented to neurology with unsteady 
gait with a normal neurological exam except for 
bilaterally absent ankle reflexes. He underwent an 
electrophysiological study that was suggestive of acute 
inflammatory demyelinating polyneuropathy (AIDP) 
(table1).  CSF analysis showed Protein 60 mg/dl, CSF 
TLC 14 (Poly 60%), CSF GLUCOSE 77 mg/dl with serum 
glucose 118 mg/dl. The blood workup for fever 
including dengue and chikungunya serology, malarial 
parasite and blood culture were sent and chikungunya 
IgM was detected.
The patient had progressive weakness involving all four 
limbs followed by severe respiratory distress and had to 
be intubated. There was no meaningful recovery 
requiring continuous respiratory support after five 
cycles of plasma exchange. He was later given 5 doses 
of IVIG which did not improve his condition. He had to 
undergo tracheostomy due to the prolonged ventilator 
support and after a month-long complicated hospital 
course, he eventually died. 
PATIENT 3:
A 43-year gentleman presented with progressive limb 
numbness and weakness with gait difficulty for 20 
days. The limb numbness initially began in bilateral 
lower limbs slowly involving the upper limbs in a glove 
and stocking pattern. He had a history of viral fever two 
weeks prior to the current symptoms. The fever was 
high grade, continuous and associated with arthralgia 
and myalgia. 
The initial neurological exam revealed a muscle 
strength of bilateral upper limb proximally 5/5 and 
distally 4/5 and in bilateral lower limb proximally and 
distally 4/5. Reflexes were absent at bilateral knee and 
ankle joints and were +1 in the bicep and triceps 
bilaterally. Sensory examination revealed decreased 
sensation in bilateral lower limbs up to the mid-thigh 
and upper limbs up to mid forearm. The nerve 
conduction study with needle electromyography was 
suggestive of acute inflammatory demyelinating 
polyneuropathy (AIDP).  CSF analysis showed 
albuminocytological dissociation as described in table 
2. The chikungunya IgM came out to be positive. He 
had five sessions of plasma exchange and significant 
clinical improvement. 
PATIENT 4:
A 36-year old right-handed lady with no prior co-morbid 
presented with sudden onset of difficulty in swallowing 
for three days followed by left arm weakness for a day. 
She had a high-grade fever associated with arthralgia 
and myalgia, severe in intensity, 3 months prior to this 
weakness. The initial neurological examination revealed 
a hypernasal speech, Right facial weakness of lower 
motor neuron type with symmetrical bulbar weakness. 
Her motor exam revealed a muscle power of -4/5 
proximally and +4/5 distally in the left upper extremity. 
The rest of the muscle groups in all other extremities 
were within normal limits. The left biceps and triceps 
reflexes were diminished (+1) with the rest of the 
reflexes being normal (+2).
She was initially suspected as a case of brainstem 
stroke and underwent MRI brain which turned out 
normal. Meanwhile, the weakness progressed involving 
the neck muscles with a power of 2/5 in the neck 
flexors and extensors. The left upper limb proximally 
was 2/5 and distally 3/5 with absent biceps and triceps 
reflexes and there was involvement of the right upper 
limb proximally the muscle strength was -4/5 and 
distally 3/5 with diminished biceps and triceps reflexes. 
The progressive bulbar, neck and asymmetric upper 
limb weakness with areflexia strongly suggested the 
diagnosis of pharyngeal-cervical-brachial (PCB) variant 
of Guillain–Barré syndrome. Myasthenia Gravis was 
ruled out by performing repeated nerve stimulation. A 
test for botulinum toxin in stool or serum was not 
performed. 
Electrophysiological showed a delayed blink reflex 
bilaterally with rapid firing units on needle electrode 
examination (table 1). CSF analysis was within normal 
limits (table 2).  Considering the prior history of fever 
associated with generalized body ache prior to this 
weakness, Chikungunya IgM serology was sent which 
came out to be positive. She was started on IVIG 
(0.4g/kg/day) but during the first day of treatment she 
progressively developed respiratory distress with type 2 
respiratory failures and had to be intubated. By day 4 of 
IVIG, she had regained some neck muscle strength and 
was extubated. She was later discharged with residual 
bulbar and facial weakness, which had completely 
resolved at one month of follow up.
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DISCUSSION:
We report the first four cases of patients developing 
GBS after infection with the chikungunya virus from 
Pakistan. While cases of GBS after infection with 
chikungunya virus have been reported before, they 
remain rare. To the best of our knowledge 17 cases of 
GBS after infection with chikungunya virus have been 
reported (1, 6-9). There is no report of this feature from 
Pakistan in any of the recent or previous outbreaks. 
Additionally, while there are case reports on AMAN 
(acute motor axonal neuropathy) and AIDP (Acute 
inflammatory demyelinating polyneuropathy) variant of 
GBS associated with chikungunya virus, we report the 
first associated case of PCB 
(Pharyngeal-cervical-brachial) and AMSAN (acute 
motor and sensory axonal neuropathy) variants of GBS. 
The diagnosis of chikungunya virus infection was based 
on Anti- chikungunya virus immunoglobulin M (IgM). 
This is detected after 3-5 days of infections and 
remains elevated for 3-6 months(10). GBS was 
diagnosed on the clinical presentation along with 
findings on electrodiagnostic studies. The presence of 
Anti- chikungunya virus IgM and the absence of signs of 
other commonly associated infections and the outbreak 
of chikungunya virus was taken to mean that GBS was 
related to the chikungunya virus infection. Similar to 
our case the other reported cases happened during 
outbreaks of chikungunya virus and an increase in the 
incidence of GBS has been reported during these 
outbreaks(6). Hence index of suspicion for GBS should 
be kept high in places with chikungunya outbreak. 
Three of our four patients had mildly elevated 
leukocytes in the CSF. This finding was not present in 
any of the other cases reported in literature.
All four patients in our series had a prior history of fever 
associated with either arthralgia or myalgia lasting for 
2-12 days. There was a symptom-free interval between 
the chikungunya virus infection and the onset of 
weakness, the duration of which varied from 5 days to 
3 months. This variation is comparable to the reported 
cases which show an onset of symptoms 3 days to 40 
days after initially experiencing fever, myalgias and 
arthralgias(1, 6-9). The course was typically 
aggressive, with 3 of our 4 patients (75%) requiring 
ventilatory support with there being one mortality. In 
the previous 17 cases reported, 6 patients (35%) 
required ventilatory support. This figure is comparable 
to the rate of respiratory failure in GBS of one patient in 
three reported in the literature(11). There were no 
deaths reported in GBS associated with chikungunya in 
the previous reports.
Of note, was the diagnostic challenge encountered in 
the fourth case with pharyngeal-cervical-brachial (PCB) 
variant of Guillain–Barré syndrome. The predominant 
signs of brainstem weakness in our case suggested a 
stroke. This, along with unfamiliarity with PCB variant of 
GBS meant early diagnosis was focused on ruling out a 
stroke. In patients with a history suggestive of features 
not consistent with a stroke, PCB should be 
considered, as early diagnosis and treatment can 
improve outcome.
CONCLUSION:
Patients may present with GBS after infection with 
chikungunya virus. This includes multiple variants of 
GBS including AIDP, AMAN, AMSAN and PCB. In places, 
with a chikungunya virus outbreak, there should be a 
high index of suspicion for GBS since this can lead to a 
timely diagnosis and treatment as the cases had a 
rapidly progressive disease course, especially 
progressing quickly to respiratory and bulbar symptoms.
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joint pain continued to restrict her mobility. On day 
seven, she experienced numbness on the left lower 
extremity followed by right lower extremity in the later 
course of the day. Next day the patient developed 
bilateral lower limb weakness without any bowel or 
bladder symptoms. The patient’s weakness was 
progressive involving upper limbs and also the face 
bilaterally with lower motor neuron type weakness. 
During the hospital course, the patient developed 
respiratory distress and was put on non-invasive BIPAP 
(Bilevel Positive Airway Pressure) support. The initial 
neurological exam revealed a power of 2/5 in bilateral 
upper limbs proximally and distally and 1/5 in the lower 
limbs along with weak flexors of the neck. Reflexes 
were absent in bilateral knee and ankle and +1 in the 
bicep and triceps bilaterally with a patchy sensory loss. 
Electrophysiological studies were done which showed 
acute motor sensory axonal neuropathy (AMSAN) 
shown in table 1. She underwent five sessions of 
plasma exchange, with a volume of two liters in each 
session. Weakness improved to a power of 4/5 in upper 
limbs and 3/5 in lower limbs with improved breathing 
after completion of five sessions. The IgM chikungunya 
antibody was detected in serum while CSF PCR was 
negative. The CSF DR showed albuminocytological 
dissociation (table 2). She was discharged and had 
complete recovery of power at one month seen in clinic 
follow-up.
PATIENT 2:
A 61-year-old gentleman who was a known case of 
diabetes, hypertension and dyslipidemia. The patient 
presented with numbness of bilateral feet and gait 
difficulties. He had a recent febrile illness 4-5 day prior 
to admission. He presented to neurology with unsteady 
gait with a normal neurological exam except for 
bilaterally absent ankle reflexes. He underwent an 
electrophysiological study that was suggestive of acute 
inflammatory demyelinating polyneuropathy (AIDP) 
(table1).  CSF analysis showed Protein 60 mg/dl, CSF 
TLC 14 (Poly 60%), CSF GLUCOSE 77 mg/dl with serum 
glucose 118 mg/dl. The blood workup for fever 
including dengue and chikungunya serology, malarial 
parasite and blood culture were sent and chikungunya 
IgM was detected.
The patient had progressive weakness involving all four 
limbs followed by severe respiratory distress and had to 
be intubated. There was no meaningful recovery 
requiring continuous respiratory support after five 
cycles of plasma exchange. He was later given 5 doses 
of IVIG which did not improve his condition. He had to 
undergo tracheostomy due to the prolonged ventilator 
support and after a month-long complicated hospital 
course, he eventually died. 
PATIENT 3:
A 43-year gentleman presented with progressive limb 
numbness and weakness with gait difficulty for 20 
days. The limb numbness initially began in bilateral 
lower limbs slowly involving the upper limbs in a glove 
and stocking pattern. He had a history of viral fever two 
weeks prior to the current symptoms. The fever was 
high grade, continuous and associated with arthralgia 
and myalgia. 
The initial neurological exam revealed a muscle 
strength of bilateral upper limb proximally 5/5 and 
distally 4/5 and in bilateral lower limb proximally and 
distally 4/5. Reflexes were absent at bilateral knee and 
ankle joints and were +1 in the bicep and triceps 
bilaterally. Sensory examination revealed decreased 
sensation in bilateral lower limbs up to the mid-thigh 
and upper limbs up to mid forearm. The nerve 
conduction study with needle electromyography was 
suggestive of acute inflammatory demyelinating 
polyneuropathy (AIDP).  CSF analysis showed 
albuminocytological dissociation as described in table 
2. The chikungunya IgM came out to be positive. He 
had five sessions of plasma exchange and significant 
clinical improvement. 
PATIENT 4:
A 36-year old right-handed lady with no prior co-morbid 
presented with sudden onset of difficulty in swallowing 
for three days followed by left arm weakness for a day. 
She had a high-grade fever associated with arthralgia 
and myalgia, severe in intensity, 3 months prior to this 
weakness. The initial neurological examination revealed 
a hypernasal speech, Right facial weakness of lower 
motor neuron type with symmetrical bulbar weakness. 
Her motor exam revealed a muscle power of -4/5 
proximally and +4/5 distally in the left upper extremity. 
The rest of the muscle groups in all other extremities 
were within normal limits. The left biceps and triceps 
reflexes were diminished (+1) with the rest of the 
reflexes being normal (+2).
She was initially suspected as a case of brainstem 
stroke and underwent MRI brain which turned out 
normal. Meanwhile, the weakness progressed involving 
the neck muscles with a power of 2/5 in the neck 
flexors and extensors. The left upper limb proximally 
was 2/5 and distally 3/5 with absent biceps and triceps 
reflexes and there was involvement of the right upper 
limb proximally the muscle strength was -4/5 and 
distally 3/5 with diminished biceps and triceps reflexes. 
The progressive bulbar, neck and asymmetric upper 
limb weakness with areflexia strongly suggested the 
diagnosis of pharyngeal-cervical-brachial (PCB) variant 
of Guillain–Barré syndrome. Myasthenia Gravis was 
ruled out by performing repeated nerve stimulation. A 
test for botulinum toxin in stool or serum was not 
performed. 
Electrophysiological showed a delayed blink reflex 
bilaterally with rapid firing units on needle electrode 
examination (table 1). CSF analysis was within normal 
limits (table 2).  Considering the prior history of fever 
associated with generalized body ache prior to this 
weakness, Chikungunya IgM serology was sent which 
came out to be positive. She was started on IVIG 
(0.4g/kg/day) but during the first day of treatment she 
progressively developed respiratory distress with type 2 
respiratory failures and had to be intubated. By day 4 of 
IVIG, she had regained some neck muscle strength and 
was extubated. She was later discharged with residual 
bulbar and facial weakness, which had completely 
resolved at one month of follow up.
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Table – 1 
Table 1: Details of the Electrophysiological findings on electromyography 
Patient SNAP’s 
(microvolt) 
Motor Nerve 
Latencies(ms) 
CMAPS 
(millivolt) 
Conduction  
Blocks 
NCV(m/sec) F waves H 
reflex 
Blink 
Studies 
EMG Diagnosis 
1. Median, 
ulnar and 
sural were 
NR 
Right median 
prolonged and 
left peroneal 
was NR. 
Low median 
ulnar, tibial 
and peroneal 
nerves. 
Not seen Slowing in 
median ,ulnar, 
peroneal and 
tibial nerves. 
All were 
NR 
except 
left ulnar 
Absent Not done RFR AMSAN 
2. Median, 
ulnar,radial 
were low 
with sural 
sparing. 
Prolonged 
median,ulnar, 
tibial and 
peroneal in 
demyelinating 
ranges. 
Low in 
median,ulnar 
,tibial and left 
peroneal 
nerves 
Block in 
left 
posterior 
tibial nerve 
Slowing in 
median,ulnar, 
peroneal and 
tibial nerves. 
Prolonge
d 
Median,
ulnar and 
tibial 
.Peroneal 
were NR 
Absent Prolonged 
Ipsi R1 
bilaterally
. 
RFR
No 
dener
vatio
n 
AIDP 
3. Median 
,ulnar and 
sural were 
NR 
Prolonged 
median,ulnar, 
tibial and 
peroneal in 
demyelinating 
ranges. 
Low in median 
,ulnar,tibial 
and peroneal 
nerves 
Block in 
right 
peroneal 
nerve. 
Slowing in 
median,ulnar, 
peroneal and 
tibial nerves 
in 
demyelinating 
range. 
All were 
NR 
Absent Not 
performed 
RFR 
No 
dener
vatio
n 
AIDP 
4. Normal Normal Low left ulnar 
and left 
axillary nerve 
None All nerves 
were within 
normal limits. 
All 
within 
normal 
limts 
Absent Prolonged 
Ipsi 
R1,Ipsi 
R2 and 
Contra R2 
bilaterally 
RFR 
No 
dener
vatio
n 
PCB 
SNAPS-Sensory nerve action potentials                       CMAPS-Compound muscle action potentials             NR-non-recordable 
NCV-Nerve conduction velocities                                EMG-Electromyography                                             RFR-Rapid firing units 
AMSAN-Acute motor sensory axonal neuropathy      AIDP-Acute inflammatory demyelinating polyneuropathy 
PCB-Pharyngeal cervical brachial variant                   Ipsi-Ipsilateral 
DISCUSSION:
We report the first four cases of patients developing 
GBS after infection with the chikungunya virus from 
Pakistan. While cases of GBS after infection with 
chikungunya virus have been reported before, they 
remain rare. To the best of our knowledge 17 cases of 
GBS after infection with chikungunya virus have been 
reported (1, 6-9). There is no report of this feature from 
Pakistan in any of the recent or previous outbreaks. 
Additionally, while there are case reports on AMAN 
(acute motor axonal neuropathy) and AIDP (Acute 
inflammatory demyelinating polyneuropathy) variant of 
GBS associated with chikungunya virus, we report the 
first associated case of PCB 
(Pharyngeal-cervical-brachial) and AMSAN (acute 
motor and sensory axonal neuropathy) variants of GBS. 
The diagnosis of chikungunya virus infection was based 
on Anti- chikungunya virus immunoglobulin M (IgM). 
This is detected after 3-5 days of infections and 
remains elevated for 3-6 months(10). GBS was 
diagnosed on the clinical presentation along with 
findings on electrodiagnostic studies. The presence of 
Anti- chikungunya virus IgM and the absence of signs of 
other commonly associated infections and the outbreak 
of chikungunya virus was taken to mean that GBS was 
related to the chikungunya virus infection. Similar to 
our case the other reported cases happened during 
outbreaks of chikungunya virus and an increase in the 
incidence of GBS has been reported during these 
outbreaks(6). Hence index of suspicion for GBS should 
be kept high in places with chikungunya outbreak. 
Three of our four patients had mildly elevated 
leukocytes in the CSF. This finding was not present in 
any of the other cases reported in literature.
All four patients in our series had a prior history of fever 
associated with either arthralgia or myalgia lasting for 
2-12 days. There was a symptom-free interval between 
the chikungunya virus infection and the onset of 
weakness, the duration of which varied from 5 days to 
3 months. This variation is comparable to the reported 
cases which show an onset of symptoms 3 days to 40 
days after initially experiencing fever, myalgias and 
arthralgias(1, 6-9). The course was typically 
aggressive, with 3 of our 4 patients (75%) requiring 
ventilatory support with there being one mortality. In 
the previous 17 cases reported, 6 patients (35%) 
required ventilatory support. This figure is comparable 
to the rate of respiratory failure in GBS of one patient in 
three reported in the literature(11). There were no 
deaths reported in GBS associated with chikungunya in 
the previous reports.
Of note, was the diagnostic challenge encountered in 
the fourth case with pharyngeal-cervical-brachial (PCB) 
variant of Guillain–Barré syndrome. The predominant 
signs of brainstem weakness in our case suggested a 
stroke. This, along with unfamiliarity with PCB variant of 
GBS meant early diagnosis was focused on ruling out a 
stroke. In patients with a history suggestive of features 
not consistent with a stroke, PCB should be 
considered, as early diagnosis and treatment can 
improve outcome.
CONCLUSION:
Patients may present with GBS after infection with 
chikungunya virus. This includes multiple variants of 
GBS including AIDP, AMAN, AMSAN and PCB. In places, 
with a chikungunya virus outbreak, there should be a 
high index of suspicion for GBS since this can lead to a 
timely diagnosis and treatment as the cases had a 
rapidly progressive disease course, especially 
progressing quickly to respiratory and bulbar symptoms.
REFERENCES
1. Agarwal A, Vibha D, Srivastava AK, Shukla G, 
Prasad K. Guillain-Barre syndrome complicating 
chikungunya virus infection. Journal of 
neurovirology. 2017;23(3):504-7.
2. Pinheiro TJ, Guimaraes LF, Silva MT, Soares CN. 
Neurological manifestations of Chikungunya and 
Zika infections. Arquivos de neuro-psiquiatria. 
2016;74(11):937-43.
3. Lewthwaite P, Vasanthapuram R, Osborne JC, 
Begum A, Plank JLM, Shankar MV, et al. 
Chikungunya Virus and Central Nervous System 
Infections in Children, India. Emerging Infectious 
Diseases. 2009;15(2):329-31.
4. Fujimura H. The Guillain-Barre syndrome. 
Handbook of clinical neurology. 
2013;115:383-402.
5. Rauf M, Fatima Tuz Z, Manzoor S, Mehmood A, 
Bhatti S. Outbreak of chikungunya in Pakistan. The 
Lancet Infectious diseases. 2017;17(3):258.
6. Oehler E, Fournier E, Leparc-Goffart I, Larre P, 
Cubizolle S, Sookhareea C, et al. Increase in cases 
of Guillain-Barre syndrome during a Chikungunya 
outbreak, French Polynesia, 2014 to 2015. Euro 
surveillance : bulletin Europeen sur les maladies 
transmissibles = European communicable disease 
bulletin. 2015;20(48):30079.
7. Lebrun G, Chadda K, Reboux A-H, Martinet O, 
Gaüzère B-A. Guillain-Barré Syndrome after 
Chikungunya Infection. Emerging Infectious 
Diseases. 2009;15(3):495-6.
8. Wielanek AC, Monredon JD, Amrani ME, Roger JC, 
Serveaux JP. Guillain-Barre syndrome complicating 
a Chikungunya virus infection. Neurology. 
2007;69(22):2105-7.
9. Villamil-Gomez W, Silvera LA, Paez-Castellanos J, 
Rodriguez-Morales AJ. Guillain-Barre syndrome 
after Chikungunya infection: A case in Colombia. 
Enfermedades infecciosas y microbiologia clinica. 
2016;34(2):140-1.
10. Prince HE, Seaton BL, Matud JL, Batterman HJ. 
Chikungunya virus RNA and antibody testing at a 
National Reference Laboratory since the 
emergence of Chikungunya virus in the Americas. 
Clinical and vaccine immunology : CVI. 
2015;22(3):291-7.
11. Azim A, Singhal S, Baronia A, Gurjar M, Poddar B, 
Singh R. Outcome of mechanical ventilation in 
patients of Guillain-Barre syndrome: An audit from 
a tertiary care centre. Sahel Medical Journal. 
2013;16(2):48-51.
joint pain continued to restrict her mobility. On day 
seven, she experienced numbness on the left lower 
extremity followed by right lower extremity in the later 
course of the day. Next day the patient developed 
bilateral lower limb weakness without any bowel or 
bladder symptoms. The patient’s weakness was 
progressive involving upper limbs and also the face 
bilaterally with lower motor neuron type weakness. 
During the hospital course, the patient developed 
respiratory distress and was put on non-invasive BIPAP 
(Bilevel Positive Airway Pressure) support. The initial 
neurological exam revealed a power of 2/5 in bilateral 
upper limbs proximally and distally and 1/5 in the lower 
limbs along with weak flexors of the neck. Reflexes 
were absent in bilateral knee and ankle and +1 in the 
bicep and triceps bilaterally with a patchy sensory loss. 
Electrophysiological studies were done which showed 
acute motor sensory axonal neuropathy (AMSAN) 
shown in table 1. She underwent five sessions of 
plasma exchange, with a volume of two liters in each 
session. Weakness improved to a power of 4/5 in upper 
limbs and 3/5 in lower limbs with improved breathing 
after completion of five sessions. The IgM chikungunya 
antibody was detected in serum while CSF PCR was 
negative. The CSF DR showed albuminocytological 
dissociation (table 2). She was discharged and had 
complete recovery of power at one month seen in clinic 
follow-up.
PATIENT 2:
A 61-year-old gentleman who was a known case of 
diabetes, hypertension and dyslipidemia. The patient 
presented with numbness of bilateral feet and gait 
difficulties. He had a recent febrile illness 4-5 day prior 
to admission. He presented to neurology with unsteady 
gait with a normal neurological exam except for 
bilaterally absent ankle reflexes. He underwent an 
electrophysiological study that was suggestive of acute 
inflammatory demyelinating polyneuropathy (AIDP) 
(table1).  CSF analysis showed Protein 60 mg/dl, CSF 
TLC 14 (Poly 60%), CSF GLUCOSE 77 mg/dl with serum 
glucose 118 mg/dl. The blood workup for fever 
including dengue and chikungunya serology, malarial 
parasite and blood culture were sent and chikungunya 
IgM was detected.
The patient had progressive weakness involving all four 
limbs followed by severe respiratory distress and had to 
be intubated. There was no meaningful recovery 
requiring continuous respiratory support after five 
cycles of plasma exchange. He was later given 5 doses 
of IVIG which did not improve his condition. He had to 
undergo tracheostomy due to the prolonged ventilator 
support and after a month-long complicated hospital 
course, he eventually died. 
PATIENT 3:
A 43-year gentleman presented with progressive limb 
numbness and weakness with gait difficulty for 20 
days. The limb numbness initially began in bilateral 
lower limbs slowly involving the upper limbs in a glove 
and stocking pattern. He had a history of viral fever two 
weeks prior to the current symptoms. The fever was 
high grade, continuous and associated with arthralgia 
and myalgia. 
The initial neurological exam revealed a muscle 
strength of bilateral upper limb proximally 5/5 and 
distally 4/5 and in bilateral lower limb proximally and 
distally 4/5. Reflexes were absent at bilateral knee and 
ankle joints and were +1 in the bicep and triceps 
bilaterally. Sensory examination revealed decreased 
sensation in bilateral lower limbs up to the mid-thigh 
and upper limbs up to mid forearm. The nerve 
conduction study with needle electromyography was 
suggestive of acute inflammatory demyelinating 
polyneuropathy (AIDP).  CSF analysis showed 
albuminocytological dissociation as described in table 
2. The chikungunya IgM came out to be positive. He 
had five sessions of plasma exchange and significant 
clinical improvement. 
PATIENT 4:
A 36-year old right-handed lady with no prior co-morbid 
presented with sudden onset of difficulty in swallowing 
for three days followed by left arm weakness for a day. 
She had a high-grade fever associated with arthralgia 
and myalgia, severe in intensity, 3 months prior to this 
weakness. The initial neurological examination revealed 
a hypernasal speech, Right facial weakness of lower 
motor neuron type with symmetrical bulbar weakness. 
Her motor exam revealed a muscle power of -4/5 
proximally and +4/5 distally in the left upper extremity. 
The rest of the muscle groups in all other extremities 
were within normal limits. The left biceps and triceps 
reflexes were diminished (+1) with the rest of the 
reflexes being normal (+2).
She was initially suspected as a case of brainstem 
stroke and underwent MRI brain which turned out 
normal. Meanwhile, the weakness progressed involving 
the neck muscles with a power of 2/5 in the neck 
flexors and extensors. The left upper limb proximally 
was 2/5 and distally 3/5 with absent biceps and triceps 
reflexes and there was involvement of the right upper 
limb proximally the muscle strength was -4/5 and 
distally 3/5 with diminished biceps and triceps reflexes. 
The progressive bulbar, neck and asymmetric upper 
limb weakness with areflexia strongly suggested the 
diagnosis of pharyngeal-cervical-brachial (PCB) variant 
of Guillain–Barré syndrome. Myasthenia Gravis was 
ruled out by performing repeated nerve stimulation. A 
test for botulinum toxin in stool or serum was not 
performed. 
Electrophysiological showed a delayed blink reflex 
bilaterally with rapid firing units on needle electrode 
examination (table 1). CSF analysis was within normal 
limits (table 2).  Considering the prior history of fever 
associated with generalized body ache prior to this 
weakness, Chikungunya IgM serology was sent which 
came out to be positive. She was started on IVIG 
(0.4g/kg/day) but during the first day of treatment she 
progressively developed respiratory distress with type 2 
respiratory failures and had to be intubated. By day 4 of 
IVIG, she had regained some neck muscle strength and 
was extubated. She was later discharged with residual 
bulbar and facial weakness, which had completely 
resolved at one month of follow up.
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Table-2 
Table 2: Details of Cerebrospinal fluid analysis 
RBC’s
DISCUSSION:
We report the first four cases of patients developing 
GBS after infection with the chikungunya virus from 
Pakistan. While cases of GBS after infection with 
chikungunya virus have been reported before, they 
remain rare. To the best of our knowledge 17 cases of 
GBS after infection with chikungunya virus have been 
reported (1, 6-9). There is no report of this feature from 
Pakistan in any of the recent or previous outbreaks. 
Additionally, while there are case reports on AMAN 
(acute motor axonal neuropathy) and AIDP (Acute 
inflammatory demyelinating polyneuropathy) variant of 
GBS associated with chikungunya virus, we report the 
first associated case of PCB 
(Pharyngeal-cervical-brachial) and AMSAN (acute 
motor and sensory axonal neuropathy) variants of GBS. 
The diagnosis of chikungunya virus infection was based 
on Anti- chikungunya virus immunoglobulin M (IgM). 
This is detected after 3-5 days of infections and 
remains elevated for 3-6 months(10). GBS was 
diagnosed on the clinical presentation along with 
findings on electrodiagnostic studies. The presence of 
Anti- chikungunya virus IgM and the absence of signs of 
other commonly associated infections and the outbreak 
of chikungunya virus was taken to mean that GBS was 
related to the chikungunya virus infection. Similar to 
our case the other reported cases happened during 
outbreaks of chikungunya virus and an increase in the 
incidence of GBS has been reported during these 
outbreaks(6). Hence index of suspicion for GBS should 
be kept high in places with chikungunya outbreak. 
Three of our four patients had mildly elevated 
leukocytes in the CSF. This finding was not present in 
any of the other cases reported in literature.
All four patients in our series had a prior history of fever 
associated with either arthralgia or myalgia lasting for 
2-12 days. There was a symptom-free interval between 
the chikungunya virus infection and the onset of 
weakness, the duration of which varied from 5 days to 
3 months. This variation is comparable to the reported 
cases which show an onset of symptoms 3 days to 40 
days after initially experiencing fever, myalgias and 
arthralgias(1, 6-9). The course was typically 
aggressive, with 3 of our 4 patients (75%) requiring 
ventilatory support with there being one mortality. In 
the previous 17 cases reported, 6 patients (35%) 
required ventilatory support. This figure is comparable 
to the rate of respiratory failure in GBS of one patient in 
three reported in the literature(11). There were no 
deaths reported in GBS associated with chikungunya in 
the previous reports.
Of note, was the diagnostic challenge encountered in 
the fourth case with pharyngeal-cervical-brachial (PCB) 
variant of Guillain–Barré syndrome. The predominant 
signs of brainstem weakness in our case suggested a 
stroke. This, along with unfamiliarity with PCB variant of 
GBS meant early diagnosis was focused on ruling out a 
stroke. In patients with a history suggestive of features 
not consistent with a stroke, PCB should be 
considered, as early diagnosis and treatment can 
improve outcome.
CONCLUSION:
Patients may present with GBS after infection with 
chikungunya virus. This includes multiple variants of 
GBS including AIDP, AMAN, AMSAN and PCB. In places, 
with a chikungunya virus outbreak, there should be a 
high index of suspicion for GBS since this can lead to a 
timely diagnosis and treatment as the cases had a 
rapidly progressive disease course, especially 
progressing quickly to respiratory and bulbar symptoms.
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joint pain continued to restrict her mobility. On day 
seven, she experienced numbness on the left lower 
extremity followed by right lower extremity in the later 
course of the day. Next day the patient developed 
bilateral lower limb weakness without any bowel or 
bladder symptoms. The patient’s weakness was 
progressive involving upper limbs and also the face 
bilaterally with lower motor neuron type weakness. 
During the hospital course, the patient developed 
respiratory distress and was put on non-invasive BIPAP 
(Bilevel Positive Airway Pressure) support. The initial 
neurological exam revealed a power of 2/5 in bilateral 
upper limbs proximally and distally and 1/5 in the lower 
limbs along with weak flexors of the neck. Reflexes 
were absent in bilateral knee and ankle and +1 in the 
bicep and triceps bilaterally with a patchy sensory loss. 
Electrophysiological studies were done which showed 
acute motor sensory axonal neuropathy (AMSAN) 
shown in table 1. She underwent five sessions of 
plasma exchange, with a volume of two liters in each 
session. Weakness improved to a power of 4/5 in upper 
limbs and 3/5 in lower limbs with improved breathing 
after completion of five sessions. The IgM chikungunya 
antibody was detected in serum while CSF PCR was 
negative. The CSF DR showed albuminocytological 
dissociation (table 2). She was discharged and had 
complete recovery of power at one month seen in clinic 
follow-up.
PATIENT 2:
A 61-year-old gentleman who was a known case of 
diabetes, hypertension and dyslipidemia. The patient 
presented with numbness of bilateral feet and gait 
difficulties. He had a recent febrile illness 4-5 day prior 
to admission. He presented to neurology with unsteady 
gait with a normal neurological exam except for 
bilaterally absent ankle reflexes. He underwent an 
electrophysiological study that was suggestive of acute 
inflammatory demyelinating polyneuropathy (AIDP) 
(table1).  CSF analysis showed Protein 60 mg/dl, CSF 
TLC 14 (Poly 60%), CSF GLUCOSE 77 mg/dl with serum 
glucose 118 mg/dl. The blood workup for fever 
including dengue and chikungunya serology, malarial 
parasite and blood culture were sent and chikungunya 
IgM was detected.
The patient had progressive weakness involving all four 
limbs followed by severe respiratory distress and had to 
be intubated. There was no meaningful recovery 
requiring continuous respiratory support after five 
cycles of plasma exchange. He was later given 5 doses 
of IVIG which did not improve his condition. He had to 
undergo tracheostomy due to the prolonged ventilator 
support and after a month-long complicated hospital 
course, he eventually died. 
PATIENT 3:
A 43-year gentleman presented with progressive limb 
numbness and weakness with gait difficulty for 20 
days. The limb numbness initially began in bilateral 
lower limbs slowly involving the upper limbs in a glove 
and stocking pattern. He had a history of viral fever two 
weeks prior to the current symptoms. The fever was 
high grade, continuous and associated with arthralgia 
and myalgia. 
The initial neurological exam revealed a muscle 
strength of bilateral upper limb proximally 5/5 and 
distally 4/5 and in bilateral lower limb proximally and 
distally 4/5. Reflexes were absent at bilateral knee and 
ankle joints and were +1 in the bicep and triceps 
bilaterally. Sensory examination revealed decreased 
sensation in bilateral lower limbs up to the mid-thigh 
and upper limbs up to mid forearm. The nerve 
conduction study with needle electromyography was 
suggestive of acute inflammatory demyelinating 
polyneuropathy (AIDP).  CSF analysis showed 
albuminocytological dissociation as described in table 
2. The chikungunya IgM came out to be positive. He 
had five sessions of plasma exchange and significant 
clinical improvement. 
PATIENT 4:
A 36-year old right-handed lady with no prior co-morbid 
presented with sudden onset of difficulty in swallowing 
for three days followed by left arm weakness for a day. 
She had a high-grade fever associated with arthralgia 
and myalgia, severe in intensity, 3 months prior to this 
weakness. The initial neurological examination revealed 
a hypernasal speech, Right facial weakness of lower 
motor neuron type with symmetrical bulbar weakness. 
Her motor exam revealed a muscle power of -4/5 
proximally and +4/5 distally in the left upper extremity. 
The rest of the muscle groups in all other extremities 
were within normal limits. The left biceps and triceps 
reflexes were diminished (+1) with the rest of the 
reflexes being normal (+2).
She was initially suspected as a case of brainstem 
stroke and underwent MRI brain which turned out 
normal. Meanwhile, the weakness progressed involving 
the neck muscles with a power of 2/5 in the neck 
flexors and extensors. The left upper limb proximally 
was 2/5 and distally 3/5 with absent biceps and triceps 
reflexes and there was involvement of the right upper 
limb proximally the muscle strength was -4/5 and 
distally 3/5 with diminished biceps and triceps reflexes. 
The progressive bulbar, neck and asymmetric upper 
limb weakness with areflexia strongly suggested the 
diagnosis of pharyngeal-cervical-brachial (PCB) variant 
of Guillain–Barré syndrome. Myasthenia Gravis was 
ruled out by performing repeated nerve stimulation. A 
test for botulinum toxin in stool or serum was not 
performed. 
Electrophysiological showed a delayed blink reflex 
bilaterally with rapid firing units on needle electrode 
examination (table 1). CSF analysis was within normal 
limits (table 2).  Considering the prior history of fever 
associated with generalized body ache prior to this 
weakness, Chikungunya IgM serology was sent which 
came out to be positive. She was started on IVIG 
(0.4g/kg/day) but during the first day of treatment she 
progressively developed respiratory distress with type 2 
respiratory failures and had to be intubated. By day 4 of 
IVIG, she had regained some neck muscle strength and 
was extubated. She was later discharged with residual 
bulbar and facial weakness, which had completely 
resolved at one month of follow up.
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DISCUSSION:
We report the first four cases of patients developing 
GBS after infection with the chikungunya virus from 
Pakistan. While cases of GBS after infection with 
chikungunya virus have been reported before, they 
remain rare. To the best of our knowledge 17 cases of 
GBS after infection with chikungunya virus have been 
reported (1, 6-9). There is no report of this feature from 
Pakistan in any of the recent or previous outbreaks. 
Additionally, while there are case reports on AMAN 
(acute motor axonal neuropathy) and AIDP (Acute 
inflammatory demyelinating polyneuropathy) variant of 
GBS associated with chikungunya virus, we report the 
first associated case of PCB 
(Pharyngeal-cervical-brachial) and AMSAN (acute 
motor and sensory axonal neuropathy) variants of GBS. 
The diagnosis of chikungunya virus infection was based 
on Anti- chikungunya virus immunoglobulin M (IgM). 
This is detected after 3-5 days of infections and 
remains elevated for 3-6 months(10). GBS was 
diagnosed on the clinical presentation along with 
findings on electrodiagnostic studies. The presence of 
Anti- chikungunya virus IgM and the absence of signs of 
other commonly associated infections and the outbreak 
of chikungunya virus was taken to mean that GBS was 
related to the chikungunya virus infection. Similar to 
our case the other reported cases happened during 
outbreaks of chikungunya virus and an increase in the 
incidence of GBS has been reported during these 
outbreaks(6). Hence index of suspicion for GBS should 
be kept high in places with chikungunya outbreak. 
Three of our four patients had mildly elevated 
leukocytes in the CSF. This finding was not present in 
any of the other cases reported in literature.
All four patients in our series had a prior history of fever 
associated with either arthralgia or myalgia lasting for 
2-12 days. There was a symptom-free interval between 
the chikungunya virus infection and the onset of 
weakness, the duration of which varied from 5 days to 
3 months. This variation is comparable to the reported 
cases which show an onset of symptoms 3 days to 40 
days after initially experiencing fever, myalgias and 
arthralgias(1, 6-9). The course was typically 
aggressive, with 3 of our 4 patients (75%) requiring 
ventilatory support with there being one mortality. In 
the previous 17 cases reported, 6 patients (35%) 
required ventilatory support. This figure is comparable 
to the rate of respiratory failure in GBS of one patient in 
three reported in the literature(11). There were no 
deaths reported in GBS associated with chikungunya in 
the previous reports.
Of note, was the diagnostic challenge encountered in 
the fourth case with pharyngeal-cervical-brachial (PCB) 
variant of Guillain–Barré syndrome. The predominant 
signs of brainstem weakness in our case suggested a 
stroke. This, along with unfamiliarity with PCB variant of 
GBS meant early diagnosis was focused on ruling out a 
stroke. In patients with a history suggestive of features 
not consistent with a stroke, PCB should be 
considered, as early diagnosis and treatment can 
improve outcome.
CONCLUSION:
Patients may present with GBS after infection with 
chikungunya virus. This includes multiple variants of 
GBS including AIDP, AMAN, AMSAN and PCB. In places, 
with a chikungunya virus outbreak, there should be a 
high index of suspicion for GBS since this can lead to a 
timely diagnosis and treatment as the cases had a 
rapidly progressive disease course, especially 
progressing quickly to respiratory and bulbar symptoms.
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